Hinge Health Reports Strong Q3 2026 Results with Raised Full-Year Revenue Guidance
Hinge Health (HNGE) delivered robust third-quarter 2026 financial results, reporting revenue of $235 million, a 52% increase year-over-year. The company's growth was driven by strong billings performance and increased enrollment yields. Profitability saw significant expansion, with non-GAAP gross margins reaching 88% and non-GAAP operating margins climbing to 33%, aided by AI-driven efficiencies and automation. Following these results, management raised its full-year 2026 revenue guidance to a range of $879 million to $881 million. The company also highlighted successful expansion into the SMB segment and integrated gastrointestinal care following the Cylinder acquisition. Despite a leadership transition involving President Jim Pursley stepping down, the firm maintains a strong liquidity position with $358.5 million in cash and investments.
Tickers: $HNGE
Topics: billings guidance raise operating margin expansion revenue growth